Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A 2-week single-blind, randomized, 3-arm proof of concept study of the effects of AIN457 (anti-IL17 antibody), ACZ885 (canakinumab, anti-IL1b antibody), or corticosteroids in patients with polymyalgia rheumatica, followed by an open label phase to assess safety and long term efficacy https://kusajili.com:443/Trial/JaPXHN14okWAVVF6ib0Q0A%24a-2-week-single-blind-randomized-3-arm-proof-of-concept-study-of-the-effects-of-ain457-anti-il17-antibody-acz885-canakinumab-an
I have read and accept the terms of use of the site and the Privacy Policy
Send your message